| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Montanova Capital, LLC is Director at BNTC and has filed Form 4s across 2 companies.
Historically, Montanova Capital, LLC's trades have earned a middling insider score of 66/100 across 17 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of +9.8%.
The biggest single holding is MANE (~$81.8M) as Director. The MANE filings lean toward selling, a net 467,326 shares.
Montanova Capital, LLC has 12 Form 4 filings on record from September 2024 to August 2026, across 2 companies: Director at Veradermics (MANE), 2026; Benitec Biopharma (BNTC), 2024–2025.
The 60 reported transactions were 49 open-market purchases, 7 option exercises, 2 open-market sales and 2 option or other derivative awards.
Counted by filing, the open-market trades come to 9 purchases worth about $46.2M and 1 sale worth about $80.4M.
The largest open-market purchase was 1,481,481 shares of BNTC at an average $13.50 on November 7, 2025, about $20.0M.
The only open-market sale was 750,000 shares of MANE at an average $107.25 on August 19, 2026, about $80.4M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | MANE Veradermics, Incorporated | Director | Sell | 750,000 | $107.25 | $80,437,500.00 | -61.9% | - | - | |
| Feb 6, 2026 | MANE Veradermics, Inc | Director, 10% Owner | Buy | 282,674 | $37.30 | $10,542,477.61 | +118.9% | +180.3% | - | |
| Dec 29, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 144,223 | $13.20 | $1,903,132.88 | +8.5% | -25.4% | - | |
| Dec 22, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 46,141 | $11.68 | $538,972.28 | +2.6% | -9.4% | - | |
| Nov 7, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 1,481,481 | $13.50 | $19,999,993.50 | +437.9% | -8.9% | - | |
| Mar 31, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 16,497 | $12.83 | $211,736.04 | +1.6% | -10.1% | -18.1% | |
| Mar 26, 2025 | BNTC Benitec Biopharma Inc. | - | Buy | 900,000 | $13.00 | $11,700,000.00 | +539.7% | +6.9% | -22.8% | |
| Dec 24, 2024 | BNTC Benitec Biopharma Inc. | - | Buy | 47,520 | $11.09 | $527,174.46 | +5.2% | +23.8% | +12.7% | |
| Dec 3, 2024 | BNTC Benitec Biopharma Inc. | - | Buy | 42,000 | $9.60 | $403,200.00 | +4.6% | +24.2% | +25.8% | |
| Nov 20, 2024 | BNTC Benitec Biopharma Inc. | - | Buy | 41,436 | $10.05 | $416,615.92 | +4.6% | +5.6% | +23.3% |